Cyclin D1 is correlated with various tumor features, and the accumulation of cyclin D1 protein in the nucleus, detected by immunohistochemistry, is suggested as an adverse risk factor in various tumors, including prostate cancer [9] and lung cancer [21]. Here, CCND1 is linked to neoplasm.